Page last updated: 2024-10-31

midazolam and Hypoparathyroidism

midazolam has been researched along with Hypoparathyroidism in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research Excerpts

ExcerptRelevanceReference
" She was managed successfully with midazolam infusion, calcium and vitamin D supplementation, and oral anti-dystonia drugs."3.85Status Dystonicus in a Child with Familial Idiopathic Hypoparathyroidism. ( Angurana, SK; Dayal, D; Ismail, J; Muralidharan, J, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angurana, SK1
Muralidharan, J1
Dayal, D1
Ismail, J1

Other Studies

1 other study available for midazolam and Hypoparathyroidism

ArticleYear
Status Dystonicus in a Child with Familial Idiopathic Hypoparathyroidism.
    Indian journal of pediatrics, 2017, Volume: 84, Issue:5

    Topics: Anti-Dyskinesia Agents; Calcium; Child; Drug Therapy, Combination; Dystonia; Female; Humans; Hypopar

2017